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Mycobacterium tuberculosis, the etiological agent of tuberculosis, has lost many coding and noncoding regions
in its genome during the course of evolution. We performed region-of-difference (RD) analysis using PCR-
based genotyping of 131 M. tuberculosis clinical isolates obtained from four different countries, namely, India,
Peru, Libya, and Angola. Our studies revealed that RD patterns are often distinct for strains circulating in
specific geographical regions and can be used to trace the descent and spread of an isolate from its original
reservoir. We describe our findings, which show that no single isolate from the four countries (n  131) had
all the 15 RDs either deleted or retained. Tuberculosis-specific deletion 1 (TbD1) was found to be conserved
in 23% of the Indian isolates, indicating their possible ancient origin. RD9 was the most conserved region,
RD11 was predominantly deleted, and RD6 was the most variable among the isolates in our collection
irrespective of their geographic region. In contrast to earlier reports, our results demonstrate that the deletion
of RD1 does not correlate with a decrease in the virulence potential of M. tuberculosis, as Indian isolates (n 
30) examined by us were from diseased individuals and yet had lost the RD1 region. Our results further
illustrated that the intactness of the RD5 region may be associated with increased virulence of the organism.
This study highlights that the RDs in M. tuberculosis genomes are geographically distributed and specific and
may possibly be associated with virulence spectrum.
Tuberculosis (TB) remains an important cause of mortality
worldwide; treatment of the disease has been further compli-
cated by the increased number of human immunodeficiency
virus-TB (HIV-TB)-coinfected patients. The future does not
appear to be bright, as no breakthrough in the development of
drugs and vaccines has been reported even after 8 years of
availability of the complete genome sequence of Mycobacte-
rium tuberculosis. Knowledge of genetic variability, mycobac-
terial population dynamics, and evolutionary genetics holds a
lot of promise for understanding epidemic potentials of strains,
their host tropism, differences in virulence, antibiotic suscep-
tibility, etc., and will be possibly important for the treatment
and control of the disease (26, 30).
Sequence analyses of the M. tuberculosis complex isolates
have revealed that allelic polymorphism is rare, occurring at
the rate of 1 in 10,000 bp (28). As a result, the genomic
fluidity in M. tuberculosis complex is largely due to nonrandom
deletions apart from mobility of insertion sequences and trans-
duction mediated by mycobacteriophages. Several PCR-based
approaches have been developed to analyze the genomic di-
versity of the M. tuberculosis complex (1, 2, 12, 15, 16, 19, 22,
25, 27, 29, 31). The available strain-typing data revealed that
regions of deletion are not randomly distributed throughout
the genome but instead tend to aggregate, suggesting that a
genomic region is vulnerable to changes which may prove del-
eterious to the pathogen. Genomic deletions provide informa-
tion on the diversity and frequency of polymorphism in the
mycobacterial populations (9). These could therefore be har-
nessed in conjunction with other genotyping techniques to
study the evolution of the M. tuberculosis complex and to pre-
dict the clonal descent of geographically partitioned strain
groups.
Recent developments in comparative genomics revealed dif-
ferences in the presence or absence of regions of differences
(RDs) and tuberculosis-specific deletion 1 (TbD1) between the
M. tuberculosis H37Rv and the M. bovis BCG. These genomic
landmarks have been described as potential markers for un-
derstanding the historical origins and genealogy of the present-
day mycobacterial pathogens (3, 5, 10). These regions harbor
several important genes and virulence factors, and their pres-
ence or absence could help identify lineages of different iso-
lates in a particular geographical region on an evolutionary
time scale. RD patterns have emerged as important for typing
systems for epidemiological and evolutionary studies of M.
tuberculosis. Subsequent studies found that some of these de-
letions were variable and were also absent from other subspe-
cies of the genus Mycobacterium (14). Of these RDs, RD3 and
RD11 are now classified as mobile genetic elements whereas
RD5 and RD6 are the insertion sequences. Some of these
RDs, namely, RD1, RD2, RD4, RD7, RD8, RD9, RD10,
RD12, RD13, RD14, and TbD1, contain the coding sequences.
Deletion or truncation of these RDs may be due to rare strand-
slippage errors of DNA polymerase, although the exact mech-
anism of such events is still elusive (5). These deletion patterns
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promise to be an important source of variability among the
members of the M. tuberculosis complex and represent unidi-
rectional genetic events having a major role in the evolution of
Mycobacterium species (3).
In this study, we attempted to analyze the distribution and
genotypic characteristics of different RDs in the genome of M.
tuberculosis isolates derived from four different geographic re-
gions. Although there is a need to analyze isolates from all over
the world to understand current global scenario of strain vari-
ation, data from some of the highly burdened countries will
nonetheless be significant from the point of view of tubercu-
losis control efforts in these countries.
MATERIALS AND METHODS
Bacterial isolates. The genomic DNAs of 131 M. tuberculosis clinical isolates
from different geographic regions were obtained from Angola (n  15), Peru (n
 38), Libya (n  48), and India (n  30). The Peruvian isolates represented
independent patient populations with and without AIDS (isolates 1 to 19 were
from HIV-negative TB patients and isolates 20 to 38 were from HIV-positive TB
patients) and were cultured at the Hospital Dos de Mayo and Hospital Maria
Auxiliadora in Lima, Peru. The Libyan strains were isolated and cultured at the
Departimento di Scienze Biomediche, Sassari, Italy, whereas the Indian isolates
(n  30) were collected from the Mahavir Hospital and Research Centre,
Hyderabad, India. Genomic DNA was extracted according to methods described
in earlier studies (24). Isolates were coded numerically according to the patient’s
geographic origin.
PCR amplification and deletion analysis. To amplify the regions of differences
in the genome of M. tuberculosis clinical isolates, PCR primers for all the 14 RDs
and TbD1 regions were designed according to the method of Brosch et al. (5).
Genomic DNA of each of the isolates was amplified with all the primer sets
specific to RDs and TbD1. The primer sets used were as follows: for RD1 (9.5-kb
genes Rv3871-Rv3879c), the internal primer pair RD1in-Rv3878F (GTC AGC
CAA GTC AGG CTA CC) and RD1in-Rv3878R (CAA CGT TGT GGT TGT
TGA GG) and the flanking primer pair RD1-flank.left (GAA ACA GTC CCC
AGC AGG T) and RD1-flank.right (TTC AAC GGG TTA CTG CGA AT) were
used; for RD2 (10.8-kb genes Rv1978-Rv1988), the internal primer pair RD2-
Rv1979.int.F (TAT AGC TCT CGG CAG GTT CC) and RD2-Rv1979-int.R
(ATC GGC ATC TAT GTC GGT GT) and the flanking primer pair RD2-
flank.F (CTC GAC CGC GAC GAT GTG C) and RD2-flank.R (CCT CGT
TGT CAC CGC GTA TG) were used; for RD3 (9.2-kb genes Rv1573-Rv1586c),
the internal primer pair RD3-Rv1586.int.F (TTA TCT TGG CGT TGA CGA
TG) and RD3-Rv1586.int.R (CAT ATA AGG GTG CCC GCT AC) and the
second internal primer pair RD3-int-REP.F (CTG ACG TCG TTG TCG AGG
TA) and RD3-int-REP.R (GTA CCC CCA GGC GAT CTT) were used; for
RD4 (12.7-kb genes Rv1505c-Rv1516c), the internal primer pair RD4-
Rv1516.int.F (CAA GGG GTA TGA GGT TCA CG) and RD4-Rv1516.int.R
(CGG TGA TTC GTG ATT GAA CA) and the flanking primer pair RD4-
flank.F (CTC GTC GAA GGC CAC TAA AG) and RD4-flank.R (AAG GCG
AAC AGA TTC AGC AT) were used; for RD5 (9.0-kb genes Rv2346c-
Rv2353c), the internal primer pair RD5A-Rv2348.int.F (AAT CAC GCT GCT
GCT ACT CC) and RD5A-Rv2348.int.R (GTG CTT TTG CCT CTT GGT C)
and the second internal primer pair RD5B-plcA.int.F (CAA GTT GGG TCT
GGT CGA AT) and RD5B-plcA.int.R (GCT ACC CAA GGT CTC CTG GT)
were used; for RD6 (4.9-kb genes Rv3425-Rv3428c), the internal primer pair
RD6-IS1532F (CAG CTG GTG AGT TCA AAT GC) and RD6-IS1532R (CTC
CCG ACA CCT GTT CGT) was used (no flanking or second internal primer
pair was used); for RD7 (12.7-kb genes Rv1964-Rv1977), the internal primer pair
RD7-Rv1976.int.F (TGG ATT GTC GAC GGT ATG AA) and RD7-
Rv1976.int.R (GGT CGA TAA GGT CAC GGA AC) and the flanking primer
pair RD7-flank.F (GGT AAT CGT GGC CGA CAA G) and RD7-flank.R
(CAG CTC TTC CCC TCT CGA C) were used; for RD8 (5.9-kb genes ephA-
lpqG), the internal primer pair RD8-ephA.F (GGT GTG ATT TGG TGA GAC
GAT G) and RD8-ephA.R (AGT TCC TCC TGA CTA ATC CAG GC) and the
flanking primer pair RD8-flank.F (CAA TCA GGG CTG TGC TAA CC) and
RD8-flank.R (CGA CAG TTG TGC GTA CTG GT) were used; for RD9
(2.0-kb genes cobL-Rv2075), the internal primer pair RD9-intF (CGA TGG
TCA ACA CCA CTA CG) and RD9-intR (CTG GAC CTC GAT GAC CAC
TC) and the flanking primer pair RD9-flankF (GTG TAG GTC AGC CCC ATC
C) and RD9-flankR (GCC CAA CAG CTC GAC ATC) were used; for RD10
(1.9-kb genes Rv0221-Rv0223), the internal primer pair RD10-intF (GTA ACC
GCT TCA CCG GAA T) and RD10-intR (GTC AAC TCC ACG GAA AGA
CC) and the flanking primer pair RD10-flankF (CTG CAA CCA TCC GGT
ACA C) and RD10-flankR (GTC ATG AAC GCC GGA CAG) were used; for
RD11 (11.0-kb genes Rv2645-Rv2659c), the internal primer pair RD11-Rv2646F
(CGG CAG CTA GAC GAC CTC) and RD11-Rv2646R (AAC GTG CTG
CGA TAG GTT TT) and the flanking primer pair RD11-fla-F (TCA CAT AGG
GGC TGC GAT AG) and RD11-fla-R (AGA GGA ACC TTT CGG TGG TT)
were used; for RD12 (2.8-kb genes sseC-Rv3121), the internal primer pair RD12-
Rv3120.int.F (GAA ATA CGA GTG CGC TGA CC) and RD12-Rv3120.int.R
(CTC TGA ACC ATC GGT GTC G) and the flanking primer pair RD12-flank.F
(GCC ATC AAC GTC AAG AAC CT) and RD12-flank.R (CGG CCA GGT
AAC AAG GAG T) were used; for RD13 (3.0-kb genes Rv1255c-Rv1257c), the
internal primer pair RD13intF (GGA TGT CAC TCG GAA CGG CA) and
RD13intR (CAC CGG GCT GAT CGA GCG A) and the flanking primer pair
RD13-flank.F (CGA TGG TGT TTC TTG GTG AG) and RD13-flank.R (GGA
TCG GCT CAG TGA ATA CC) were used; for RD14 (9.0-kb genes Rv1765c-
Rv1773c), the internal primer pair RD14-Rv1769.int.F (GTG GAG CAC CTT
GAC CTG AT) and RD14-Rv1769.int.R (CGT CGA ATA CGA GTC GAA
CA) and the flanking primer pair RD14-flankF (TTG ATT CGC CAA CAA
CTG AA) and RD14-flankR (GGG CTG GTT AGT GTC GAT TC) were used;
and for TbD1 (genes mmpS6 and mmpL6), the internal primer pair TBD1intS.F
(CGT TCA ACC CCA AAC AGG TA) and TBD1intS.R (AAT CGA ACT CGT
GGA ACA CC) and the flanking primer pair TBD1fla1-F (CTA CCT CAT CTT
CCG GTC CA) and TBD1fla1-R (CAT AGA TCC CGG ACA TGG TG) were
used.
Each PCR assay was carried out with a 20-l reaction mixture containing 50
nM of each primer, 10 mM Tris-HCl (pH 8.8), 50 mM KCl, 1.5 mM MgCl2,
0.01% gelatin, 10% dimethyl sulfoxide, 200 M nucleotide mix, 1 U Taq poly-
merase, and 1 to 10 ng of template DNA, and the volume was made up with
sterile distilled water. After denaturation at 95°C for 3 min, the reaction mixture
was processed for another 35 cycles at 95°C for 30 s, 58°C for 1 min, and 72°C for
4 min followed by 72°C for 10 min in a Gene Amp 9700 system (Perkin-Elmer).
The amplicons were visualized by electrophoresis, which was carried out at 125
V for 1 h on a 1% agarose gel in Tris-acetate-EDTA buffer, and the amplicon
sizes were estimated by comparison with a 1-kb Plus DNA ladder (Gibco BRL,
Life Technologies). Deletion polymorphism were scored based on the size of
different amplicons on an agarose gel. The RD region was amplified with flank-
ing primers; for confirmation purposes, amplification using internal primers was
also performed. All the methods in this regard were optimized as suggested by
Brosch et al. (6).
RESULTS
RDs are geographically partitioned. The genomic DNAs of
131 M. tuberculosis isolates belonging to four countries were
screened for 15 loci (14 RDs and TbD1). On the basis of
deletion markers, a dendrogram was constructed to under-
stand the genetic relationships and distances among the iso-
lates from the four countries. Data of all 131 isolates were used
in a binary format for construction of an unrooted tree based
on the information of RD patterns (Fig. 1). The tree thus
obtained clearly revealed four distinct clusters. As expected,
isolates belonging to a specific geographical region clustered
together as a single group. They grouped into four clusters,
namely, Angola (isolates 1 to 15), Peru (isolates 1 to 19 and 20
to 38), Libya (isolates 1 to 48), and India (isolates 1 to 30).
Each cluster was found to be geographically specific. Each
region-specific major cluster was divided into subclusters on
the basis of the variation in the RD patterns. The 15 RDs
analyzed for 131 isolates formed 62 distinct patterns. No sim-
ilar RD patterns were found among isolates belonging to dif-
ferent countries.
Distribution of deletion polymorphism among our isolates.
Out of the total of 131 isolates tested, only 8 (6.1%) retained
the TbD1 region (Fig. 2). The TbD1 region was present in
seven (23%) of the Indian isolates and accounts for 5.3% of
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the total isolates analyzed, indicating that these isolates prob-
ably represent the ancient gene pool. A single Angolan isolate
(Angola 7) retained this region. All the isolates from Peru and
Libya showed the absence of the TbD1. All the clinical isolates
of Indian origin analyzed by us lacked the RD1 region. How-
ever, the extent of RD1 deletion in strains of other regions was
comparatively less. Forty percent of Angolan isolates had de-
letions of RD1. The RD1 deletion was also observed in 21% of
Libyan and 2.6% of Peruvian isolates.
Among the 131 isolates we tested, RD9 was deleted only in
five isolates (Angola 1, 3, and 11 and Peru 1 and 3) and present
in 126 (96%) isolates. Therefore, RD9 was found to be the
most conserved RD among the isolates tested. The RD11
region was absent in 98% of Libyan, 84% of Peruvian, and
80% of Angolan isolates, and all the Indian M. tuberculosis
isolates tested lacked this region. The RD10 and RD14 regions
were present in 100% of Indian and Angolan isolates. The
RD10, RD13, and RD14 regions were present in 97% of Pe-
ruvian isolates. The RD7 region was absent in about 94% of
Angolan and 84% of Peruvian isolates. The RD2, RD3, and
RD4 regions were totally absent in all the Peruvian and Indian
isolates and also absent in 80%, 87%, and 20% of the Angolan
isolates, respectively. The RD8 region was absent in all the
Indian isolates, whereas RD12 and RD5 were absent in Peru-
vian and Angolan isolates, respectively. On the other hand,
RD2, RD3, RD4, RD5, RD6, RD8, and RD12 were retained
in the majority of Libyan isolates.
FIG. 1. A radial dendrogram depicting four M. tuberculosis clusters belonging to four different countries constructed based on binary data using
the neighbor joining method.
FIG. 2. RD distribution. The overall scenario for the presence
(RP) or absence (RA) of a specific region is shown.
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Overall, we found RD9 to be the most conserved, RD11 to
be predominantly deleted, and RD6 as to be the most variable
one, irrespective of the origin of isolates. No single isolate
among all the four countries (n  131) had all the 15 RDs
either deleted or retained. One of the Peruvian isolates (Peru
3) had lost all the RDs except RD5, whereas the three Libyan
isolates (Libya 19, Libya 26, and Libya 30) retained 12 RDs
and lost only three RDs (TbD1, RD11, and RD13). Each of
these isolates was found to have a deletion of at least 3 RDs
out of 15 RDs tested; these deletions account for 20% of the
total region of differences.
Region-wise distribution of signature RDs. The distribution
of deletion polymorphism in our international collection of
isolates, based on the presence or absence of 15 regions of
differences, revealed significant regional diversity. The pres-
ence of RD9, RD10, andRD14 could be regarded as the sig-
nature of the Indian isolates. The presence of RD10, RD13,
and RD14 was, however, specific to Angolan isolates. Libyan
isolates almost always revealed a signature represented by the
intactness of RD4, RD9, and RD12. Interestingly, the missing
RD5 and RD6 regions in all the Indian isolates correlated with
low or null copy numbers of insertion element IS6110, whereas
these two RDs were present in majority of the Libyan isolates.
DISCUSSION
The comparative genomics tools have created an unprece-
dented opportunity to undertake large-scale sequence compar-
isons among the M. tuberculosis complex organisms. Various
approaches such as bacterial artificial chromosome arrays (4,
10), subtractive hybridization (18), and DNA microarrays (3,
20) have identified several small or large regions of differences
among the members of the M. tuberculosis complex. Genomic
deletions have been an important driving force in the chromo-
somal evolution of the M. tuberculosis complex (5, 14, 23).
These deletion events often arise due to recombination be-
tween adjacent insertion sequence (IS) elements (6, 8). The
genome of tubercle bacilli houses more than 40 IS and mobile
genetic elements that could mediate deletion events (7) inde-
pendent of some of the rare strand-slippage errors of DNA
polymerases. Genomic deletion analysis of the M. tuberculosis
complex bacilli confirmed its usefulness in deducing the origins
and descent of circulating strains of M. tuberculosis complex in
different countries (5, 13, 20, 30). The genes from RD regions
showed great variability among certain members of the M.
tuberculosis complex, and some new specific deletions in M.
canettii, M. microti, and seal isolates have been identified (20).
Genomic deletions represent unidirectional genetic events in
the evolution of M. bovis BCG (3) and have been described to
be potentially significant in documenting clonal descent of the
strains.
In the present study, we sought to validate the use of
genomic deletion markers to characterize a collection of
strains originating from four different countries of the world
for which such an analysis has not been done previously.
RD analysis of 131 isolates revealed four major geographical
clusters, making this perhaps the first report that demonstrates
specific, biogeographic distribution of RD signatures in the
chromosomes of M. tuberculosis isolates from different coun-
tries. The distribution of the observed deletions may help in
understanding their order of occurrence during the course of
bacterial evolution (21, 26). The TbD1 junction sequence con-
servation is a perfect indicator that differentiates ancient and
modern isolates. This study demonstrated that 23% of the
Indian M. tuberculosis isolates have a conserved TbD1 region
and thus may be regarded as “ancient” in origin. This obser-
vation further substantiates the results of a recent study per-
formed in our laboratories (2).
The genes present in the RD1 region have been described to
be essential for M. tuberculosis virulence, and loss of RD1 was
previously shown to be associated with BCG attenuation (17).
Our study provide a further indication that virulence may not
be necessarily dictated by the presence of RD1 region, as all
the Indian clinical isolates analyzed by us showed a deleted
RD1, given the fact that they were obtained from patients with
active tuberculosis.
All but five of the isolates from our collection harbored
RD9, the deletion of which is considered a signature of M.
africanum and M. tuberculosis complex bacteria other than M.
tuberculosis (3, 22). Our isolates that revealed RD9 deletion
were probably M. tuberculosis complex bacteria and not M.
tuberculosis.
We also attempted to differentiate Peruvian isolates recov-
ered from HIV-seropositive and -seronegative patients. All the
Peruvian isolates analyzed with 15 RDs did not show any
significant difference between these two categories. However,
one of these isolates (Peru 3) recovered from an HIV-sero-
negative patient showed deletions of 14 RDs from its genome
but not deletion of RD5, which is comprised of eight genes,
two of which code for ESAT-6-like proteins with unknown
functions (5). All other Peruvian and Indian isolates, however,
showed deletions of most of the RDs. In this connection, it was
interesting that low-copy-number IS6110 isolates from India
did not carry RD5. Recent observations revealed that the low-
copy-number IS6110 strains of principle genetic group 1 pre-
dominate south Asian regions and are described as low in
virulence (11). However, it is too early to speculate on an
association of RD5 with virulence. The presence or absence of
different genomic deletions in different strains might possibly
be dictated by the selection pressures exerted by the host
immune mechanisms (and the genetic background) determin-
ing the repertoire of various RDs in different strains. Further,
these mechanisms might actually shape the genome content of
the bacterium over time, which in turn suggests that successive
loss of DNA facilitates appearance of more-successful patho-
gens in certain kind of hosts (5).
In conclusion, we find evidence of an association between
RD patterns and the biogeographic evolution of strains. The
TbD1 region was more frequently present in most of the In-
dian isolates, supporting the concept that Indian M. tuberculo-
sis strains are more “ancient.” Our study also provokes second
thoughts on the deletion of RD1 and suggests that this may not
decrease the virulence potential of M. tuberculosis. This is
because a majority of the Indian patient isolates from diseased
individuals lacked this region. Similarly, other genes present
within the RD 5 loci may also be important from the perspec-
tive of geographic evolution and impact of host factors. In the
future, it may be of interest to carefully compare the virulence
properties of strains with different RD profiles by using a
variety of available animal models to obtain novel insights into
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the evolutionary dynamics and virulence mechanisms of this
major pathogen. Secondly, our study demonstrated the poten-
tial of deletion markers in lineage identification, phylogeny,
and molecular epidemiology and may therefore be used in
conjunction with the existing typing methods. We suggest that
RD analysis of a larger number of M. tuberculosis isolates from
various geographic regions may give more insights and con-
tribute to our understanding of the evolution, epidemiology,
and pathogenicity of M. tuberculosis.
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